The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)

Interventions for valvular disease

TAVI

TAVI, now an established, valid treatment for patients presenting with symptomatic severe aortic stenosis, has proven to be superior to medical treatment for inoperable patients whilst being a valid alternative to surgery in select, high-risk patients. This topic covers the newest devices and emerging data in TAVI as well as information on tools, devices and techniques such as vascular access; the role of adjunctive pharmacotherapy; imaging techniques such as echocardiography, understanding bleeding risks or patient selection.

Filters

Search by author
Filter by type
Showing 1-20 of 224 articles
Interventions for valvular disease
Thirty-day Clinical Outcomes of the Evolut PRO Self-Expanding Transcatheter Aortic Valve: The International FORWARD PRO Study
Manoharan G, Grube E, Van Meighem NM, Brecker S, Fiorina C, Kornowski R, Danenberg H, Ruge H, Thiele H, Lancellotti P, Søndergaard L, Tamburino C, Oh JK, Fan Y, Windecker S
August 4, 2020 | 10.4244/EIJ-D-20-00279
Interventions for valvular disease
Clinical Outcomes of TAVI or SAVR in Men and Women with Aortic Stenosis at Intermediate Operative Risk: a post hoc analysis of the randomized SURTAVI trial
Van Mieghem N, Reardon M, Yakubov SJ, Heiser J, Merhi W, Windecker S, Makkar R, Cheng W, Robbins M, Fail P, Feinberg E, Stoler RC, Hebeler R, Serruys P, Popma J
July 21, 2020 | 10.4244/EIJ-D-20-00303
Coronary interventions
EAPCI Core Curriculum for Percutaneous Cardiovascular Interventions (2020): Committee for Education and Training European Association of Percutaneous Cardiovascular Interventions (EAPCI) A branch of the European Society of Cardiology
Van Belle E, Teles RC, Pyxaras S, Kalpak O, Johnson T, Barbash IM, De Luca G, Kostov J, Parma R, Vincent F, Brugaletta S, Debry N, Toth G, Ghazzal Z, Deharo P, Milasinovic D, Kaspar K, Saia F, Mauri J, Kammler J, Muir D, O'Connor S, Mehilli J, Thiele H, Weilenmann D, Witt N, Joshi F, Kharbanda R, Piroth Z, Wojakowski W, Geppert A, Di Gioia G, Pires-Morais G, Petronio AS, Estevez-Loureiro R, Ruzsa Z, Kefer J, Kunadian V, Van Mieghem N, Windecker S, Baumbach A, Haude M, Dudek D
July 7, 2020 | 10.4244/EIJ-D-18-00448
Interventions for valvular disease
Virtual reality assisted conscious sedation during transcatheter aortic valve implantation – a randomized pilot study
Bruno RR, Lin Y, Wolff G, Polzin A, Veulemans V, Klein K, Westenfeld R, Zeus T, Kelm M, Jung C
June 30, 2020 | 10.4244/EIJ-D-20-00269
Interventions for valvular disease
Systematic use of intentional leaflet laceration to prevent TAVI-induced coronary obstruction: feasibility and early clinical outcomes of the BASILICA technique
Kitamura M, Majunke N, Holzhey D, Desch S, Bani Hani A, Krieghoff C, Gutberlet M, Protsyk V, Ender J, Borger MA, Dvir D, Thiele H, Abdel-Wahab M
June 30, 2020 | 10.4244/EIJ-D-20-00386
Interventions for valvular disease
Transaxillary compared with transcarotid access for TAVR: a propensity-matched comparison from a French multicenter registry
Debry N, Trimech TR, Gandet T, Vincent F, Hysi I, Delhaye C, Cayla G, Koussa M, Juthier F, Leclercq F, Pécheux M, Ghostine S, Labreuche J, Modine T, Van Belle E, Bical A, Denimal T, Pamart T, Spillemaeker H, Verdier B, Cosenza A, Coisne A, Porouchani S, Sudre A, Mugnier A, Rousse N, Loobuyck V, Vincentelli A, Macia JC, Akodad M, Fabre O, Gommeaux A, Schmutz L, Moussa MD, Robin E, Azmoun A
May 29, 2020 | 10.4244/EIJ-D-20-00117
Interventions for valvular disease
Long-term Outcomes of Valve-in-Valve Transcatheter Aortic Valve Implantation for Degenerate Homograft Aortic Valve Replacement
Duncan A, Davies A, Quarto C, Davies S
May 19, 2020 | 10.4244/EIJ-D-20-00450
Interventions for valvular disease
Outcomes of Valve-In-Valve Transcatheter Aortic Valve Replacement in Patients with Failed Bioprosthetic Aortic Valves: Systematic Review and Meta-analysis of Observational Evidence
Mahmoud AN, Gad MM, Elgendy I, Mahmoud AA, Taha Y, Elgendy AY, Ahuja KR, Saad AM, Simonato M, McCabe JM, Reisman M, Kapadia S, Dvir D
May 19, 2020 | 10.4244/EIJ-D-19-00928
Interventions for valvular disease
Technical considerations for repeat TAVI in the failing Direct Flow transcatheter heart valve
Yap J, Southard JA, Wong GB, Singh GD, Stripe BR
May 12, 2020 | 10.4244/EIJ-D-20-00426
Interventions for valvular disease
Implications of Hinge-Point Based Annular Plane with Abnormal Aortic Cusps in Transcatheter Aortic Valve Replacement: Advantage of Centerline Based Annular Plane Approach
Pasala T, Jelnin V, Sahyoun C, Dudiy Y, Ruiz C
May 4, 2020 | 10.4244/EIJ-D-19-00760
Interventions for valvular disease
Assessing the risk for coronary obstruction after transcatheter aortic valve implantation and the need to perform BASILICA: the VIVID classification
Tang G, Komatsu I, Tzemach L, Simonato M, Wolak A, Blanke P, Dvir D
May 4, 2020 | 10.4244/EIJ-D-20-00067
Interventions for valvular disease
CT-scan theoretical analysis for aortic cross-clamp and opening after transcatheter aortic valve implantation
Belluschi I, Buzzatti N, Romano V, De Backer O, Søndergaard L, Karady J, Maurovich-Horvat P, Rahgozar K, De Bonis M, Castiglioni A, Colombo A, Alfieri O, Montorfano M, Latib A
May 4, 2020 | 10.4244/EIJ-D-19-00991
Interventions for valvular disease
A review of recommendations for infective endocarditis prevention in patients undergoing transcatheter aortic valve implantation
Conen A, Stortecky S, Moreillon P, Hannan MM, Franzeck FC, Jeger R, Widmer AF
March 24, 2020 | 10.4244/EIJ-D-19-00993
Interventions for valvular disease
The Retro-antegrade Approach to Paravalvular Leak Closure After Transcatheter Aortic Valve Replacement
So C, Kang G, Lee JC, Eng MH
March 17, 2020 | 10.4244/EIJ-D-19-01122
Interventions for valvular disease
First pilot study with the TriGUARD 3 Cerebral Embolic Protection Device
Magalhaes P, Kooistra N, Leenders G, Margolis P, Lansky A, Kraaijeveld A, Voskuil M, Stella P
February 25, 2020 | 10.4244/EIJ-D-19-00741
Interventions for valvular disease
Predictors and Safety of Next-Day Discharge in Unselected Patients Undergoing Transfemoral Transcatheter Aortic Valve Implantation
Costa G, Barbanti M, Picci A, Todaro D, La Spina K, Di Simone E, D’Arrigo P, Criscione E, Valvo R, Reddavid C, Deste W, Sgroi C, Tamburino C, Giuffrida A, Garretto V, Privitera G, Cannizzaro M, Inserra C, Veroux P
February 25, 2020 | 10.4244/EIJ-D-19-01080
Interventions for valvular disease
Feasibility and safety of transcaval transcatheter aortic valve implantation: a multicentre European registry
Costa G, De Backer O, Pilgrim T, Kasel A, Redwood S, Aminian A, Lanz J, Michel J, Patterson T, Windecker S, Prendergast B, Greenbaum A, Søndergaard L
February 7, 2020 | 10.4244/EIJ-D-19-00797
Interventions for valvular disease
Incidence and predictors of vascular complications in transaxillary TAVI
van der Wulp K, Thijs I, van Wely M, Loverbos A, Gehlmann H, Verkroost M, Van Garsse L, Kievit P, Vart P, El Messaoudi S, Bosboom D, Morshuis W, van Royen N
February 7, 2020 | 10.4244/EIJ-D-19-00588
Interventions for valvular disease
Impact of implant depth on hydrodynamic function of the ALLEGRA bioprosthesis in valve-in-valve interventions
Sathananthan J, Fraser R, Kütting M, Hensey M, Landes U, Alkhodair A, Sedaghat A, Blanke P, Toggweiler S, Leipsic J, Søndergaard L, Wood D, Webb J
February 7, 2020 | 10.4244/EIJ-D-19-00782
Interventions for valvular disease
Early haemodynamic changes and long-term outcome of patients with severe low-gradient aortic stenosis after transcatheter aortic valve replacement
Schewel J, Schlüter M, Schmidt T, Kuck K, Frerker C, Schewel D
January 17, 2020 | 10.4244/EIJ-D-19-00399
Coronary
Valvular disease
Heart failure
Peripheral
Hypertension
Stroke